Studies of Plasma Quinidine Content: II. Relation to Toxic Manifestations and Therapeutic Effect

Circulation - United States
doi 10.1161/01.cir.1.4.569
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)